SCHEMBL8308833

SCHEMBL8308833

CC(=NOCCOC1CCCCO1)c1ccc(-c2ccccc2)nc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.48
OXTR P30559 3/20 0.43
AVPR1A P37288 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4C Q9H3R0 1/20 0.42
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HPGDS O60760 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LDHA P00338 1/20 0.36
BAZ2B Q9UIF8 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
S1PR1 P21453 1/20 0.33
CYP3A4 P08684 1/20 0.33
GABRA5 P31644 1/20 0.33
USP30 Q70CQ3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3083559 0.84 L3MBTL1 (0.47) PPARGMEN1KMT2AKDM4CNPC1
SCHEMBL3083561 0.84 L3MBTL1 (0.47) PPARGMEN1KMT2AKDM4CNPC1
SCHEMBL8304479 0.83 NPC1 (0.43) MEN1KMT2AKDM4CNPC1RAB9A
SCHEMBL8387426 0.82 MEN1 (0.42) PPARGMEN1KMT2AKDM4CNPC1
SCHEMBL8304680 0.82 MEN1 (0.42) MEN1KMT2AKDM4CNPC1RAB9A
SCHEMBL8310012 0.81 KDM4C (0.43) MEN1KMT2AKDM4CNPC1RAB9A
SCHEMBL8307747 0.81 MEN1 (0.39) MEN1KMT2AKDM4CNPC1RAB9A
SCHEMBL8309324 0.80 MEN1 (0.41) MEN1KMT2AKDM4CNPC1RAB9A
SCHEMBL8304494 0.79 KDM4C (0.44) OXTRAVPR1AMEN1KMT2AKDM4C
SCHEMBL3088344 0.79 KDM4C (0.48) PPARGMEN1KMT2AKDM4CNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed